Investment
Features
FeesSafety
Academy
More
Pluang+

Compare JBS N.V. Class A Common Shares (JBS) vs UiPath Inc (PATH) Price & Performance

JBS N.V. Class A Common SharesTrade
UiPath IncTrade

Price performance (Past 24H)

Key statistics

JBS N.V. Class A Common Shares vs UiPath Inc — how do they compare? JBS N.V. Class A Common Shares trades at $13 (market cap $13.86B), while UiPath Inc trades at $12.94 (market cap $6.91B). The key difference: JBS N.V. Class A Common Shares is far larger — about 2× UiPath Inc's market cap, and JBS N.V. Class A Common Shares pays a 10.38% dividend while UiPath Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold JBS N.V. Class A Common Shares for 0 Days and UiPath Inc for 139 Days on average.

JBSPATH
Market Cap
$13.86B$6.91B
Volume
4,980,04926,239,123
Sector
Consumer StaplesTechnology
52-Week High
$18.42$19.29
52-Week Low
$10.86$9.38
Typical Hold Time
0 Days139 Days
Enterprise Value
$34.83B$5.70B
Dividend Yield
10.38%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

JBS N.V. Class A Common Shares

JBS trades at $12.93, up 0.54% today, with a neutral technical signal and strong analyst buy consensus. The stock shows attractive valuation with a P/E of 12.08 and P/S of 0.47, though recent quarterly EPS misses and a declining profit margin to 1.22% in 2026 highlight earnings pressure. Recent news includes a proposal to acquire full control of Pilgrim's Pride and a joint venture in Southeast Asia, indicating strategic expansion.

The outlook is mixed: analyst targets suggest ~40% upside to $18.17, but risks include execution on acquisitions, margin compression, and volatile beef markets. Cash flow turned positive in 2026 projections, supporting growth initiatives, yet debt levels and competitive pressures warrant caution for investors seeking stability.

UiPath Inc

UiPath (PATH) trades at $13.06, down 1.95% on the day, with a bullish technical signal from moving averages but neutral oscillators. Revenue growth is robust, increasing from $1.3B in 2024 to $1.43B in 2025, with a projected net profit of $362M in 2026. Recent news highlights expanded AI partnerships and raised guidance, though the stock faces near-term volatility.

The outlook is cautiously optimistic, with a consensus price target of $15.13 offering potential upside. Key opportunities include strong enterprise demand and AI monetization, while risks involve competitive pressures and execution challenges in achieving profitability targets. Analyst sentiment is mixed, with a majority hold rating.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

JBS
100% Buy0% Sell
Avg holding period · 0 Days
PATH
51% Buy49% Sell
Avg holding period · 139 Days

Top news

Latest headlines on both assets

About JBS N.V. Class A Common Shares

JBS N.V. is a protein-processing company producing beef, pork, poultry, lamb, fish, and plant-based products, headquartered in São Paulo and Amsterdam. It operates more than 250 production facilities across over 16 countries under brands including Friboi, Seara, Swift, and Pilgrim's, and is the majority shareholder of Pilgrim's Pride Corporation.

Read more on JBS →

About UiPath Inc

UiPath Inc creates an end-to-end platform that provides automation with user emulation at its core. Its platform is built to be used by employees throughout a company and to address a wide variety of use cases, from simple tasks to long-running, complex business processes. It generates revenue from the sale of licenses for its proprietary software, maintenance and support, and professional services. It generates a majority of the revenues from the US, followed by Romania and the rest of the world.

Read more on PATH →